ResMed (NYSE:RMD) FY Conference Transcript

ResMed (NYSE:RMD) FY Conference January 12, 2026 01:30 PM ET Company ParticipantsMick Farrell - CEOConference Call ParticipantsChris Cooper - AnalystChris CooperOkay, good morning and welcome again to the J.P. Morgan Healthcare Conference. My name is Chris Cooper. I cover the Australian healthcare stocks here at J.P. Morgan. This man needs no introduction, but I'd like to hand over here to Mick Farrell, the CEO of ResMed.Mick FarrellGreat. Well, thanks, Chris, and look forward to having about 20 minutes of ...